Checkpoint Therapeutics Inc (NASDAQ:CKPT) has a beta value of 1.23 and has seen 10.33 million shares traded in the last trading session. The company, currently valued at $195.33M, closed the last trade at $4.00 per share which meant it gained $0.02 on the day or 0.50% during that session. The CKPT stock price is -12.5% off its 52-week high price of $4.50 and 65.5% above the 52-week low of $1.38.
The consensus among analysts is that Checkpoint Therapeutics Inc (CKPT) is Buy stock at the moment, with a recommendation rating of 2.33. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.
Checkpoint Therapeutics Inc (NASDAQ:CKPT) trade information
Sporting 0.50% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the CKPT stock price touched $4.00 or saw a rise of 1.96%. Year-to-date, Checkpoint Therapeutics Inc shares have moved 25.00%, while the 5-day performance has seen it change 52.09%. Over the past 30 days, the shares of Checkpoint Therapeutics Inc (NASDAQ:CKPT) have changed 21.58%.
Checkpoint Therapeutics Inc (CKPT) estimates and forecasts
The company’s shares have gained 90.48% over the past 6 months. Revenue growth from the last financial year stood is estimated to be -100.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 26.32% over the past 5 years.
CKPT Dividends
Checkpoint Therapeutics Inc is expected to release its next earnings report in April this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . As of Dec 31, 2024 , the former fund manager holds about 2.27% shares in the company for having 1.09 shares of worth $4.37 million while later fund manager owns 732.7 shares of worth $2.93 million as of Dec 31, 2024 , which makes it owner of about 1.52% of company’s outstanding stock.